Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4527595
Max Phase: Preclinical
Molecular Formula: C86H135N19O16S
Molecular Weight: 1723.21
Molecule Type: Unknown
Associated Items:
ID: ALA4527595
Max Phase: Preclinical
Molecular Formula: C86H135N19O16S
Molecular Weight: 1723.21
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)NCCCOCCOCCOCCCNC(=O)C[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNCC(=O)O)[C@@H](C)O)C(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C86H135N19O16S/c1-3-4-5-6-7-8-9-10-11-12-13-14-24-39-71(107)93-42-28-45-119-47-49-121-50-48-120-46-29-43-94-72(108)53-64(51-61-30-18-15-19-31-61)98-79(113)68(38-26-41-96-86(89)90)100-82(116)70(58-122)102-80(114)67(37-25-40-95-85(87)88)99-73(109)54-66-36-27-44-105(66)84(118)78(76(62-32-20-16-21-33-62)63-34-22-17-23-35-63)104-81(115)69(52-65-55-92-59-97-65)101-83(117)77(60(2)106)103-74(110)56-91-57-75(111)112/h15-23,30-35,55,59-60,64,66-70,76-78,91,106,122H,3-14,24-29,36-54,56-58H2,1-2H3,(H,92,97)(H,93,107)(H,94,108)(H,98,113)(H,99,109)(H,100,116)(H,101,117)(H,102,114)(H,103,110)(H,104,115)(H,111,112)(H4,87,88,95)(H4,89,90,96)/t60-,64+,66+,67+,68+,69+,70-,77+,78+/m1/s1
Standard InChI Key: RVBWIOOQFHBIRR-ANLLVINGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1723.21 | Molecular Weight (Monoisotopic): 1722.0055 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2016) 7 (8): [10.1039/C6MD00260A] |
Source(1):